PHS
DNDN

PFM Health Sciences’s DENDREON CORPORATION DNDN Stock Holding History

PFM Health Sciences’s Portfolio DNDN Stock Details DNDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,007,813
Closed -$6M – 98
2013
Q4 		$6M Buy
+2,007,813
New +$5.65M 0.12% 59

Other funds holding DNDN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

PFM Health Sciences's DNDN Position: Q1 2014 in Review

PFM Health Sciences sold out of DENDREON CORPORATION (DNDN) in Q1 2014, closing a stake of 2,007,813 shares — an estimated $6M sold.

PFM Health Sciences first reported a position in DNDN in Q4 2013 and held it in 1 quarter. The position peaked at $6M in Q4 2013. 128 funds tracked by Wall St. Rank hold DNDN as of Q1 2014.

  • PFM Health Sciences reported no remaining DENDREON CORPORATION position as of Q1 2014 after selling out during the quarter.
  • PFM Health Sciences sold 2,007,813 DENDREON CORPORATION shares in Q1 2014, an estimated $6M.
  • PFM Health Sciences first reported a position in DENDREON CORPORATION in Q4 2013 and held it in 1 quarter.
  • PFM Health Sciences's DENDREON CORPORATION position peaked at $6M in Q4 2013.
  • 128 funds tracked by Wall St. Rank held DENDREON CORPORATION as of Q1 2014.

Based on PFM Health Sciences's 13F filing for Q1 2014, filed 15 May 2014.